Get the Stockscreener App
24.55
0.53%
0.13
Progyny Inc stock is traded at $24.55, with a volume of 1.42M.
It is up +0.53% in the last 24 hours and up +21.35% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$24.42
Open:
$24.07
24h Volume:
1.42M
Relative Volume:
1.00
Market Cap:
$2.11B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
38.97
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+9.75%
1M Performance:
+21.35%
6M Performance:
+12.31%
1Y Performance:
+75.61%
1-Day Range:
$23.75
$24.72
1-Week Range:
$22.21
$24.86
52-Week Range:
$13.39
$26.76
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
24.55 | 2.11B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
321.86 | 301.21B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
77.81 | 100.59B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
325.83 | 72.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
269.66 | 72.36B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
237.12 | 28.47B | 123.11B | 1.58B | 2.44B | 13.03 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
How Progyny Inc. stock reacts to global recession fearsWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Applying chart zones and confluence areas to Progyny Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Visual analytics tools that track Progyny Inc. performance - newser.com
Is Progyny Inc. stock resilient to inflationPortfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Can Progyny Inc. stock resist market sell offsGold Moves & Daily Entry Point Alerts - newser.com
Progyny (PGNY) Is Up 35.6% After Strong Earnings, Raised Guidance, and $200M Buyback Announcements - simplywall.st
What MACD and RSI say about Progyny Inc.2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
How Progyny Inc. stock performs in interest rate cycles2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Fundação Cultural do Pará
5 Must-Read Analyst Questions From Progyny's Q3 Earnings Call - Finviz
Progyny, Inc. to Present at Jefferies Global Healthcare Conference - The Globe and Mail
How hedge fund analytics apply to Progyny Inc. stockPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
Progyny seesaws amid confusion over impact from Trump’s IVF initiative - MSN
5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call - Yahoo Finance
Keybanc Upgrades Progyny (PGNY) - Nasdaq
Progyny upgraded to Overweight from Sector Weight at KeyBanc - MSN
Progyny (PGNY) Upgraded by KeyBanc with Promising Catalysts Ahea - GuruFocus
Progyny upgraded at KeyBanc on catalysts over next year - Seeking Alpha
Progyny Shares Rise After KeyBanc Upgrade - MarketScreener
Progyny price target raised to $26 from $25 at JPMorgan - TipRanks
KeyBanc upgrades Progyny stock rating to Overweight on positive catalysts By Investing.com - Investing.com Australia
This AT&T Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Progyny (PGNY) Upgraded to Overweight by Keybanc, Price Target S - GuruFocus
KeyBanc Upgrades Progyny to Overweight From Sector Weight, Sets $30 Price Target - MarketScreener
KeyBanc upgrades Progyny to Overweight on ’emerging’ catalysts - MSN
Progyny, Inc. Surpasses Expectations in Earnings Call - MSN
KeyBanc upgrades Progyny stock rating to Overweight on positive catalysts - Investing.com
Trading the Move, Not the Narrative: (PGNY) Edition - news.stocktradersdaily.com
KeyBanc Upgrades Progyny (PGNY) as Positive Catalysts Emerge - GuruFocus
Progyny, Inc. (NASDAQ:PGNY) Q3 2025 Earnings Call Transcript - MSN
JP Morgan Maintains Progyny (PGNY) Neutral Recommendation - Nasdaq
Progyny, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PGNY) 2025-11-11 - Seeking Alpha
PGNY Analyst Update: JP Morgan Maintains Rating, Raises Price Ta - GuruFocus
Truist Raises Price Target on Progyny to $28 From $27, Keeps Hold Rating - MarketScreener
Chart based exit strategy for Progyny Inc.Exit Point & Verified High Yield Trade Plans - newser.com
Progyny, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
Progyny, Inc. Hits Day High with 24.21% Surge in Stock Price - Markets Mojo
Top News - Markets Financial Content
Progyny Inc : Jefferies Raises Target Price t - 富途牛牛
Can trapped investors hope for a rebound in Progyny Inc.Volume Spike & Real-Time Volume Analysis Alerts - newser.com
Why Progyny (PGNY) Is Up 19.6% After Raising Earnings Guidance and Announcing a $200M Buyback - Yahoo Finance
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):